Treatment with the new modified insulin glargine (Semglee) in a patient with type 1 diabetes mellitus: case report

Česká verzia

Authors: Alexandra Brečková
Authors place of work: MEDIKARD, s. r. o., Prešov
Published in the journal: Diab Obez 2020; 20(39): 61-62
Category: Case studies

Zdroje

Handelsman Y, Mechanick JI, Blonde L et al [AACE Task Force for Developing Diabetes Comprehensive Care Plan]. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract 2011; 17(Suppl 2): S1-S53. Dostupné z DOI: <http://dx.doi.org/10.4158/ep.17.s2.1>.
Patel A, MacMahon S, Chalmers J et al. [ADVANCE Collaborative Group]. Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes. N Engl J Med 2008; 358(24): 2560–2572. Dostupné z DOI: <http://dx.doi.org/10.1056/NEJMoa0802987>.
Mokáň M, Martinka E, Galajda P. Diabetes mellitus a vybrané metabolické ochorenia. P+M: Martin 2008. ISBN 9788096971398.
Dravecká I. Liečba prandiálnymi premixovanými analógmi. Diabetes a obezita 2012; 12(24): 9–14.
Galajda P, Šutarík Ľ, Mokáň M et al. Liečba inzulínovou pumpou a kontinuálne glukózové monitorovanie pri diabetes mellitus 1. typu z pohľadu medicíny založenej na dôkazoch. Diabetes a obezita 2013; 13(25): 69–79.
Kvapil M (eds). Diabetologie 2013. Triton: Praha 2013. ISBN 978–80–7387–656–2.
Bartoš V, Pelikánová T et al. Praktická diabetologie. 5 ed. Maxdorf: Praha 2011. ISBN 978–80–7345–244–5.